2 results
Approved WMOCompleted
The primary objective is to assess the efficacy of sirukumab as measured by the reduction of the signs and symptoms of RA in subjects with active RA who are refractory to an anti-TNF Alpha agent. The secondary objectives are to assess the following…
Approved WMOCompleted
To determine the effect of botulinum toxin type A injections in stroke patients with stiff knee gait.